Renaissance Technologies's LRMR Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 297,266 shares of Larimar Therapeutics, Inc. (LRMR) worth $1.13 M, representing 0.00% of the portfolio. First purchased in 2020-Q2, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in LRMR, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 461,429 shares. Largest reduction occurred in Q4 2025, reducing 561,376 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Larimar Therapeutics (LRMR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Larimar Therapeutics (LRMR) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -561,376 | Reduce 65.38% | 297,266 | $3.81 |
| Q3 2025 | +296,900 | Add 52.85% | 858,642 | $3.23 |
| Q2 2025 | -413,229 | Reduce 42.38% | 561,742 | $2.89 |
| Q1 2025 | +461,429 | Add 89.85% | 974,971 | $2.15 |
| Q4 2024 | +159,700 | Add 45.13% | 513,542 | $3.87 |
| Q3 2024 | +75,500 | Add 27.12% | 353,842 | $6.55 |
| Q2 2024 | -225,100 | Reduce 44.71% | 278,342 | $7.25 |
| Q1 2024 | +256,400 | Add 103.79% | 503,442 | $7.59 |
| Q4 2023 | +1,700 | Add 0.69% | 247,042 | $4.55 |
| Q3 2023 | -36,232 | Reduce 12.87% | 245,342 | $3.95 |
| Q2 2023 | +98,832 | Add 54.08% | 281,574 | $0.00 |
| Q1 2023 | -46,032 | Reduce 20.12% | 182,742 | $0.00 |
| Q4 2022 | -67,593 | Reduce 22.81% | 228,774 | $0.00 |
| Q3 2022 | +120,825 | Add 68.83% | 296,367 | $3.20 |
| Q2 2022 | +2,800 | Add 1.62% | 175,542 | $1.96 |
| Q1 2022 | -20,032 | Reduce 10.39% | 172,742 | $4.05 |
| Q4 2021 | -53,500 | Reduce 21.72% | 192,774 | $10.79 |
| Q3 2021 | +50,500 | Add 25.80% | 246,274 | $11.53 |
| Q2 2021 | -16,700 | Reduce 7.86% | 195,774 | $9.82 |
| Q1 2021 | -8,900 | Reduce 4.02% | 212,474 | $14.61 |
| Q4 2020 | +22,300 | Add 11.20% | 221,374 | $21.41 |
| Q3 2020 | -9,500 | Reduce 4.55% | 199,074 | $15.17 |
| Q2 2020 | +208,574 | New Buy | 208,574 | $12.85 |
Renaissance Technologies's Larimar Therapeutics Investment FAQs
Renaissance Technologies first purchased Larimar Therapeutics, Inc. (LRMR) in Q2 2020, acquiring 208,574 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Larimar Therapeutics, Inc. (LRMR) for 23 quarters since Q2 2020.
Renaissance Technologies's largest addition to Larimar Therapeutics, Inc. (LRMR) was in Q1 2025, adding 974,971 shares worth $2.1 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 297,266 shares of Larimar Therapeutics, Inc. (LRMR), valued at approximately $1.13 M.
As of the Q4 2025 filing, Larimar Therapeutics, Inc. (LRMR) represents approximately 0.00% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Larimar Therapeutics, Inc. (LRMR) was 974,971 shares, as reported at the end of Q1 2025.